1. Apparent diffusion coefficient in the analysis of prostate cancer: determination of optimal b-value pair to differentiate normal from malignant tissue
    Nuno Adubeiro et al, 2018, Clinical Imaging CrossRef
  2. A Prostate Specific Antigen Immunosensor Based on Biotinylated-Antibody/Cyclodextrin Inclusion Complex: Fabrication and Electrochemical Studies
    Mir F. Mousavi et al, 2017, Electroanalysis CrossRef
  3. Electrochemical aptamer-based biosensor developed to monitor PSA and VEGF released by prostate cancer cells
    Bruno P. Crulhas et al, 2017, Anal Bioanal Chem CrossRef
  4. The molecular biology of prostate cancer: current understanding and clinical implications
    Jason Gandhi et al, 2017, Prostate Cancer Prostatic Dis CrossRef
  5. Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsies
    Christa Haldrup et al, 2018, Mol Oncol CrossRef
  6. Understanding the Catalytic Machinery and the Reaction Pathway of the Malonyl-Acetyl Transferase domain of human Fatty Acid Synthase
    Pedro Paiva et al, 2018, ACS Catal. CrossRef
  7. Metabolic alterations in urine extracellular vesicles are associated to prostate cancer pathogenesis and progression
    Marc Clos-Garcia et al, 2018, Journal of Extracellular Vesicles CrossRef
  8. Current advances and future visions on bioelectronic immunosensing for prostate-specific antigen
    Conlathan Ibau et al, 2017, Biosensors and Bioelectronics CrossRef
  9. Dynamic Contrast-Enhanced Imaging as a Prognostic Tool in Early Diagnosis of Prostate Cancer: Correlation with PSA and Clinical Stage
    Xingchen Wu et al, 2018, Contrast Media & Molecular Imaging CrossRef
  10. An efficient MRI agent targeting extracellular markers in prostate adenocarcinoma
    Amerigo Pagoto et al, 2018 CrossRef
  11. Using an Electrochemical Aptasensor to Early Detect Prostate Specific and Free Prostate-Specific Antigens Released by Cancer Cells
    João P. R. L. L. Parra et al, 2018, Electroanalysis CrossRef
  12. KLF4, A Gene Regulating Prostate Stem Cell Homeostasis, Is a Barrier to Malignant Progression and Predictor of Good Prognosis in Prostate Cancer
    Xiaozhong Xiong et al, 2018, Cell Reports CrossRef
  13. Clinical relevance of gene expression in localized and metastatic prostate cancer exemplified by FABP5.
    K Nitschke et al, 2020, World J Urol CrossRef
  14. Fibronectin Regulation of Integrin B1 and SLUG in Circulating Tumor Cells
    Jeannette Huaman et al, 2019, Cells CrossRef
  15. Human Fatty Acid Synthase: A Computational Study of the Transfer of the Acyl Moieties from MAT to the ACP Domain
    Pedro Paiva et al, 2019, ChemCatChem CrossRef
  16. null
    Wenke Liu et al, 2019 CrossRef
  17. Human Prostasomes an extracellular vesicle – Biomarkers for Male Infertility and Prostrate Cancer: The Journey from Identification to Current Knowledge
    A.S. Vickram et al, 2019, International Journal of Biological Macromolecules CrossRef
  18. A review of studies examining the association between genetic biomarkers (short tandem repeats and single-nucleotide polymorphisms) and risk of prostate cancer: the need for valid predictive biomarkers
    Mohammed H. Albujja et al, 2019, Prostate International CrossRef
  19. Emerging proteomics biomarkers and prostate cancer burden in Africa
    Henry A. Adeola et al, 2017, Oncotarget CrossRef
  20. Circulating Tumor Cell Migration Requires Fibronectin Acting through Integrin B1 or SLUG
    Jeannette Huaman et al, 2020, Cells CrossRef
  21. Evaluation of E2F3 and survivin expression in peripheral blood as potential diagnostic markers of prostate cancer
    Ahmed M. Wadaa Allah et al, 2020 CrossRef
  22. null
    Iago Dillion Lima Cavalcanti et al, 2021 CrossRef
  23. Methylation pattern of tumor-suppressor gene promoters as putative noninvasive diagnostic markers for prostate cancer
    O. S. Mankovska et al, 2021, Biopolym. Cell CrossRef
  24. Serum gonadotropins, cortisol, PSA, and micronutrient levels among men with prostate carcinoma
    Wasiu Eniola Olooto et al, 2021, Afr J Urol CrossRef
  25. Multiplexed Prostate Cancer Companion Diagnostic Devices
    Josephine Aidoo-Brown et al, 2021, Sensors CrossRef
  26. Glycosylated biomarker sensors: advancements in prostate cancer diagnosis
    Siti Fatimah Abd Rahman et al, 2021, Chem. Commun. CrossRef
  27. Towards reliable diagnostics of prostate cancer via breath
    K. S. Maiti et al, 2021, Sci Rep CrossRef
  28. Voided urine test to diagnose prostate cancer: Preliminary report
    R.B. Nerli et al, 2021, Cytojournal CrossRef
  29. Graphene quantum dot based ultrasensitive probe for biosensing of prostate cancer biomarkers: current updates and future challenges
    Jidnyasa Pantwalawalkar et al, 2022, Adv. Nat. Sci: Nanosci. Nanotechnol. CrossRef
  30. Anticancer activity of Alpinia purpurata (Vieill) K. Schum. against MNU and testosterone induced prostate cancer in male Wistar albino rats
    Anusooriya Palanirajan et al, 2022, Pharmacological Research - Modern Chinese Medicine CrossRef
  31. The health effects of soy: A reference guide for health professionals
    Mark Messina et al, 2022, Front. Nutr. CrossRef
  32. Comparison of Internal Dosimetry of 18F-PSMA-1007 and 68Ga-PSMA-11-HBED-CC
    Priya Sharma et al, 2022, Clin Nucl Med CrossRef
  33. Detection of Prostate Cancer Biomarker PCA3 by Using Aptasensors
    Bruno P. Crulhas et al, 2022, CMC CrossRef